Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 251-260 of 508 for center for individualized medicine

Edit search filters
  1. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™

    Rochester, MN

  2. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations

    Rochester, MN

  3. A Study Of AL101 In Patients with Adenoid Cystic Carcinoma Bearing Activating Notch Mutations

    Rochester, MN

  4. The Establishment of an Allogeneic Cartilage Bank for the Center for Regenerative Medicine

    Rochester, MN

  5. Study of Generating and Banking Clinical-grade Stem Cells for Regenerative Medicine

    Jacksonville, FL

  6. International Precision Medicine Consortium for Neurooncology Research

    Rochester, MN

  7. Patient-Centered Exploration to Understand their perception of comprehensive regenerative care

    Rochester, MN

  8. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Patient-Specific Induced Pluripotent Stem Cell Models for Heritable Channelopathies and Cardiomyopathies

    Rochester, MN

  10. Analysis of Orthobiologic Agents (OBA) for Painful Musculoskeletal Conditions and Tissue Regeneration

    Jacksonville, FL

.

Mayo Clinic Footer